SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-13-000043
Filing Date
2013-05-10
Accepted
2013-05-10 11:03:17
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q quarterly_report-033113.htm 10-Q 576487
2 AMENDMENT NO. 3 ALKERMES exhibit_10-1.htm EX-10.1 67111
3 AMENDMENT NO. 3 BIOGEN exhibit_10-2.htm EX-10.2 33883
4 CEO CERTIFICATION exhibit_31-1.htm EX-31.1 14963
5 CFO CERTIFICATION exhibit_31-2.htm EX-31.2 14981
6 CEO CERTIFICATION exhibit_32-1.htm EX-32.1 6526
7 CFO CERTIFICATION exhibit_32-2.htm EX-32.2` 6606
  Complete submission text file 0001008848-13-000043.txt   6025761

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acor-20130331.xml EX-101.INS 502740
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20130331.xsd EX-101.SCH 89083
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20130331_cal.xml EX-101.CAL 56492
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20130331_def.xml EX-101.DEF 372521
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20130331_lab.xml EX-101.LAB 1387621
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20130331_pre.xml EX-101.PRE 612759
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 13831684
SIC: 2836 Biological Products, (No Diagnostic Substances)